Expiring Contracts — NAICS 325412

PHARMACEUTICAL PREPARATION MANUFACTURING

681 contracts with NAICS code 325412 expiring within the next 18 months.

Showing 451-475 of 681 results
36C25726N0098191 days remaining

DALLAS VA PHARMACY COMPOUNDING FOR ONCOLOGY DRUGS

OPTUM INFUSION SERVICES 308, LLC|Department of Veterans Affairs|Expires Oct 26, 2026
$1.2M
36C25726N0098191 days remaining

DALLAS VA PHARMACY COMPOUNDING FOR ONCOLOGY DRUGS

OPTUM INFUSION SERVICES 308, LLC|Department of Veterans Affairs|Expires Oct 26, 2026
$1.2M
36C25226N0198196 days remaining

REVLIMID, POMALYST, CAMZYOS SPECIALTY PHARMACEUTICALS

BRISTOL-MYERS SQUIBB COMPANY|Department of Veterans Affairs|Expires Oct 31, 2026
$848,445
36C24226N0216196 days remaining

PLUVICTO (LUTETIUM LU 177 VIPIVOTIDE TETRA 27MCI/ML)

NOVARTIS PHARMACEUTICALS CORPORATION|Department of Veterans Affairs|Expires Oct 31, 2026
$813,476.16
36C24226N0216196 days remaining

PLUVICTO (LUTETIUM LU 177 VIPIVOTIDE TETRA 27MCI/ML)

NOVARTIS PHARMACEUTICALS CORPORATION|Department of Veterans Affairs|Expires Oct 31, 2026
$299,062.26
36C24724F0045196 days remaining

PYLARIFY QTY 80

PROGENICS PHARMACEUTICALS INC|Department of Veterans Affairs|Expires Oct 31, 2026
$1.8M
36C24926N0218196 days remaining

PYLARIFY PET RADIOPHARMACEUTICAL ORDERING PERIOD 3

PROGENICS PHARMACEUTICALS INC|Department of Veterans Affairs|Expires Oct 31, 2026
$966,231.75
36C25226N0198196 days remaining

REVLIMID, POMALYST, CAMZYOS SPECIALTY PHARMACEUTICALS

BRISTOL-MYERS SQUIBB COMPANY|Department of Veterans Affairs|Expires Oct 31, 2026
$848,445
36C24226N0216196 days remaining

PLUVICTO (LUTETIUM LU 177 VIPIVOTIDE TETRA 27MCI/ML)

NOVARTIS PHARMACEUTICALS CORPORATION|Department of Veterans Affairs|Expires Oct 31, 2026
$299,062.26
36C26026N0052196 days remaining

RADIOPHARMACEUTICALS FOR NUCLEAR MEDICINE VA PATIENTS.

CARDINAL HEALTH 108, LLC|Department of Veterans Affairs|Expires Oct 31, 2026
$209,272.21
36C26026F0054196 days remaining

I-123 DATSCAN RADIOPHARMACEUTICAL.

MEDI-PHYSICS, INC.|Department of Veterans Affairs|Expires Oct 31, 2026
$78,116.64
36C25026F0109196 days remaining

RADIOPHARMACEUTICAL - FLYRCADO

GE HEALTHCARE INC|Department of Veterans Affairs|Expires Oct 31, 2026
$114,000
36C24926N0218196 days remaining

PYLARIFY PET RADIOPHARMACEUTICAL ORDERING PERIOD 3

PROGENICS PHARMACEUTICALS INC|Department of Veterans Affairs|Expires Oct 31, 2026
$962,609.7
36C26226F0051196 days remaining

PIFLUFOLASTAT F 18 - PYLARIFY

PROGENICS PHARMACEUTICALS INC|Department of Veterans Affairs|Expires Oct 31, 2026
$1.1M
36C25726N0066196 days remaining

I-123 DATSCAN

MEDI-PHYSICS, INC.|Department of Veterans Affairs|Expires Oct 31, 2026
$153,443.4
36C26226N0112196 days remaining

PLUVICTO AND LUTATHERA

NOVARTIS PHARMACEUTICALS CORPORATION|Department of Veterans Affairs|Expires Oct 31, 2026
$3.9M
36C25026N0149196 days remaining

FIVE YEAR FOR PET ISOTOPES

PETNET SOLUTIONS, INC.|Department of Veterans Affairs|Expires Oct 31, 2026
$396,000
36C25723P0016196 days remaining

IV ROOM AND HOOD TESTING

HEALTH SYSTEMS SCIENCES, LLC|Department of Veterans Affairs|Expires Oct 31, 2026
$315,652.33
15B41126P00000004196 days remaining

FY26 B1 MCKESSON OM-PO OCT 25 RP# 26-0018

MCKESSON CORPORATION|Department of Justice|Expires Oct 31, 2026
36C25726N0093196 days remaining

AMARILLO VA PHARMACY COMPOUNDING FOR ONCOLOGY MEDICATIONS

OPTUM INFUSION SERVICES 308, LLC|Department of Veterans Affairs|Expires Oct 31, 2026
$225,000
36C24426N0108199 days remaining

ILLUCCIX

NUCLEAR DIAGNOSTIC PRODUCTS OF PHILADELPHIA, INC|Department of Veterans Affairs|Expires Nov 3, 2026
$564,500
36C26226F0031199 days remaining

DELIVERY ORDER FOR PYLARIFY

PROGENICS PHARMACEUTICALS INC|Department of Veterans Affairs|Expires Nov 3, 2026
$1.6M
36C24626N0306200 days remaining

ISOTOPES PHARMACEUTICALS

PETNET SOLUTIONS, INC.|Department of Veterans Affairs|Expires Nov 4, 2026
$379,441.8
36C25726N0241202 days remaining

LENALIDOMIDE ORAL MED

EXELAN PHARMACEUTICALS INC|Department of Veterans Affairs|Expires Nov 6, 2026
$899,347.26
15B51826F00000048209 days remaining

PROVIDE VARIOUS MAT MEDICATION FOR THE INMATE POPULATION AT FCC OAKDALE FOR FY26.

MCKESSON CORPORATION|Department of Justice|Expires Nov 13, 2026
$105,217.97